One under-$10 stock that's trending very close to trigger a major breakout trade is Peregrine Pharmaceuticals (PPHM), which is developing first-in-class monoclonal antibodies for the treatment and diagnosis of cancer. This stock has been uptrending modestly so far in 2013, with shares up 8.3%.
If you take a look at the chart for Peregrine Pharmaceuticals, you'll notice that this stock has recently put in a triple bottom chart pattern at $1.20, $1.29 and $1.27 a share. This stock is now starting to bounce off those support levels, and it's quickly moving within range of triggering a major breakout trade. If that triple bottom can hold, then shares of PPHM could be setting up for a monster move higher.Traders should now look for long-biased trades in PPHM if it manages to break out above its 200-day moving average at $1.58 and its 50-day moving average at $1.62 a share and then above some more resistance at $1.68 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 5.12 million shares. If that breakout triggers soon, then PPHM will set up to re-test or possibly take out its next major overhead resistance levels at $2.40 to $2.78 a share. Any high-volume move above $2.78 would then put a huge gap down zone from last September into play that started at $5.50 a share. Traders can look to buy PPHM off any weakness to anticipate that breakout and simply use a stop that sits just below some key near-term support levels at $1.27 to $1.20 a share. One can also buy PPHM off strength once it takes out those breakout levels with volume and then simply use a stop that sits just below $1.40 a share. I would add to either position once PPHM takes out $1.68 a share with heavy volume. The shorts are pretty involved in this stock, since its current short interest as a percentage of the float for PPHM is 9.7%. If that breakout triggers soon, then PPHM could get squeezed higher as the bears rush to cover some of their short bets.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV